info@biomedres.us
+1 (502) 904-2126
One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA
Site Map
ISSN: 2574 -1241
ISSN: 2574 -1241
Received: September 08, 2017; Published: September 25, 2017
DOI: 10.26717/BJSTR.2017.01.000390
OV immunotherapy is an important emerging cancer treatment modality which uses native or genetically modified viruses to destroy cancers. MM is perhaps the ideal malignancy to target using OVs because of the virus permissivity of neoplastic plasma cells and the diseaseassociated immune paresis. OVs have the potential to mediate both tumor debulking and residual disease elimination avoiding the complex and prolonged current therapy for multiple myeloma.
Keywords : OVs: Oncolytic Viruses; MTD: Maximum Tolerated Dose; MM: Multiple Myeloma
Introduction| Oncolytic viruses| Virotherapy of Multiple Myeloma| Conclusion| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China
Full Text
PDF
